Clinical trial · Interventional
Evaluation Of Cardiovascular Health Outcomes Among Survivors 2
Evaluation Of Cardiovascular Health Outcomes Among Survivors 2 (ECHOS2)
NCT07245420CI-TRIAL-00116090recruitingN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Childhood cancer survivors who received certain treatments are at a higher risk of developing heart problems in the future. This study is looking at ways to educate childhood cancer survivors about that risk and encourage them to receive a recommended heart screening test.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Health Behavior | — | UNRESOLVED | — |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Healthy Hearts eHealth Program | Behavioral | — | UNRESOLVED |
| Survivorship Care Plan + Educational Materials (delivered via CIAS platform) | Behavioral | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- ACTIVE_COMPARATOR
- label
- Standard of Care (SOC)
- description
- Participants receive a personalized survivorship care plan and educational materials about cardiomyopathy risk and screening recommendations.
- interventionNames
- Behavioral: Survivorship Care Plan + Educational Materials (delivered via CIAS platform)
- type
- EXPERIMENTAL
- label
- Healthy Hearts eHealth Intervention
- description
- Participants receive the same SOC materials plus a tailored eHealth intervention using CIAS. This includes avatar-led motivational interviewing, survivor video vignettes, and interactive modules addressing screening barriers.
- interventionNames
- Behavioral: Healthy Hearts eHealth Program
Primary outcomes (2)
- measure
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 26 Years
Show eligibility criteria text
Inclusion Criteria: * Childhood Cancer Survivor Study (CCSS) Participants * Age ≥26 years * Treated with cumulative doxorubicin equivalent anthracycline doses ≥100 mg/m2 with any/no radiation, or ≥15 Gy chest radiation with any/no anthracyclines * No history of cardiomyopathy * Has not had an echocardiogram in the previous 5 years * Has a history of successful completion of CCSS surveys * English-Speaking * Has not been enrolled in ECHOS-1 (pilot) Exclusion Criteria: • Currently participating in a long-term follow-up program that provides risk-based screening
References
Publications (0)
Data not yet available
No reference posted for this study.